Suchergebnisse - "Salvatierra, Juan"

PubPharm (21)

1

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

enthalten in: Medicina clinica | 2023

von Aomar-Millán, I. | Fatoul-Del Pino, G. | Torres-Parejo, �. | +3

2

Dexamethasone versus weight-adjusted methylprednisolone in patients with moderate-severe SARS-CoV-2 pneumonia

enthalten in: Medicina clinica (English ed.) | 2023

von Aomar-Millán, I. | Fatoul-Del Pino, G. | Torres-Parejo, �. | +3

3

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab : comment

enthalten in: Reumatologia clinica | 2023

von Aomar-Millán, I. | Salvatierra, J. | Callejas-Rubio, J. | +1

4

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab : coment

enthalten in: Reumatologia clinica | 2023

von Aomar-Millán, I. | Salvatierra, J. | Callejas-Rubio, J. | +1

5

Characteristics and clinical outcome in 312 patients with moderate to severe pneumonia due to SARS-COV-2 and hyperinflammation treated with anakinra and corticosteroids : A retrospective cohort study

enthalten in: PloS one | 2023

von Aomar-Millán, I. | de Victoria-Carazo, J. | Fernández Reyes, D. | +8

6

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia

enthalten in: Medicina clinica | 2022

von Aomar-Millán, I. | Salvatierra, J. | Raya Álvarez, E.

CommentOn: Med Clin (Engl Ed). 2022 Apr 8;158(7):301-307. - PMID 35531306

7

Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia

enthalten in: Medicina clinica (English ed.) | 2022

von Aomar-Millán, I. | Salvatierra, J. | Raya Álvarez, E.

CommentIn: Med Clin (Barc). 2022 Oct 28;159(8):e55. - PMID 35945056

8

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation

enthalten in: Medicina clinica | 2021

von Aomar-Millán, I. | Salvatierra, J. | Torres-Parejo, �. | +3

9

Glucocorticoids alone versus tocilizumab alone or glucocorticoids plus tocilizumab in patients with severe SARS-CoV-2 pneumonia and mild inflammation

enthalten in: Medicina clinica (English ed.) | 2021

von Aomar-Millán, I. | Salvatierra, J. | Torres-Parejo, �. | +3

10

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study : reply

enthalten in: Internal and emergency medicine | 2021

von Aomar-Millán, I. | Salvatierra, J. | Hernández-Quero, J.

CommentOn: Intern Emerg Med. 2021 Jun;16(4):1101-1103. - PMID 33598871